Q1 EPS Estimate for Trevi Therapeutics Lifted by Analyst
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Trevi Therapeutics in a note issued to investors on Tuesday, March 18th. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings of ($0.10) per share for the quarter, up from their […]
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Trevi Therapeutics in a note issued to investors on Tuesday, March 18th. Leerink Partnrs analyst F. Khurshid now expects that the company will post earnings of ($0.10) per share for the quarter, up from their […]
